How Big Pharma Tried to Weaken the Rules of the UN’s Nature Fund
As the COP17 nature summit gets underway in Armenia, evidence has emerged of lobbying by a leading international pharmaceuticals group to weaken the terms of a flagship fund for nature. Documents analysed by DeSmog show that the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) called for a “radical rethink”Continue Reading












